Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,242 | 478 | 99.5% |
| Gift | $49.99 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,148 | 178 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,005 | 45 | $0 (2024) |
| Janssen Biotech, Inc. | $978.97 | 45 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $718.91 | 30 | $0 (2023) |
| PFIZER INC. | $539.30 | 30 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $477.26 | 26 | $0 (2024) |
| Celgene Corporation | $322.39 | 16 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $284.31 | 15 | $0 (2024) |
| Gilead Sciences, Inc. | $254.94 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $154.73 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $781.74 | 36 | Takeda Pharmaceuticals U.S.A., Inc. ($138.71) |
| 2023 | $1,616 | 79 | ABBVIE INC. ($309.32) |
| 2022 | $1,285 | 64 | ABBVIE INC. ($492.97) |
| 2021 | $1,443 | 74 | AbbVie Inc. ($659.94) |
| 2020 | $812.50 | 43 | AbbVie Inc. ($377.73) |
| 2019 | $986.87 | 50 | Takeda Pharmaceuticals U.S.A., Inc. ($391.42) |
| 2018 | $1,104 | 65 | AbbVie, Inc. ($365.04) |
| 2017 | $1,261 | 70 | AbbVie, Inc. ($551.74) |
All Payment Transactions
481 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.41 | General |
| 06/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Immunology | ||||||
| 06/03/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Immunology | ||||||
| 05/29/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Gastroenterology | ||||||
| 05/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/01/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Gastroenterology | ||||||
| 04/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/24/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Gastroenterology | ||||||
| 04/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 04/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.09 | General |
| Category: GI | ||||||
| 03/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/06/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Gastroenterology | ||||||
| 03/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 02/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $36.33 | General |
| 02/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: CNS | ||||||
| 02/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Gastroenterology | ||||||
| 02/16/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $29.59 | General |
| Category: Neuroscience | ||||||
| 02/14/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: GI | ||||||
| 02/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.74 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 401 | 423 | $231,885 | $37,302 |
| 2022 | 8 | 248 | 272 | $139,789 | $20,858 |
| 2021 | 9 | 327 | 361 | $200,551 | $33,281 |
| 2020 | 9 | 347 | 381 | $227,171 | $34,865 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 55 | 63 | $5,733 | $2,703 | 47.2% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 14 | 15 | $10,020 | $1,311 | 13.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $2,912 | $1,033 | 35.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 34 | 34 | $37,332 | $6,818 | 18.3% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 63 | 63 | $61,362 | $6,313 | 10.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 82 | 112 | $16,912 | $5,875 | 34.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 72 | 73 | $62,488 | $5,422 | 8.7% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 33 | 33 | $26,961 | $4,481 | 16.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 18 | $7,542 | $3,069 | 40.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $3,584 | $1,365 | 38.1% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 13 | 14 | $9,352 | $944.53 | 10.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 17 | 18 | $1,638 | $577.25 | 35.2% |
About Dr. Amer Malik, MD
Dr. Amer Malik, MD is a Gastroenterology healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679560684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amer Malik, MD has received a total of $9,292 in payments from pharmaceutical and medical device companies, with $781.74 received in 2024. These payments were reported across 481 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($9,242).
As a Medicare-enrolled provider, Malik has provided services to 1,323 Medicare beneficiaries, totaling 1,437 services with total Medicare billing of $126,306. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Riverside, RI
- Active Since 10/04/2005
- Last Updated 01/12/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1679560684
Products in Payments
- STELARA (Biological) $945.94
- ZENPEP (Drug) $718.91
- LINZESS (Drug) $559.70
- HUMIRA (Biological) $527.38
- Creon (Drug) $499.32
- ENTYVIO (Biological) $449.53
- Humira (Biological) $404.79
- Entyvio (Biological) $395.89
- XIFAXAN (Drug) $367.44
- ZEPOSIA (Drug) $307.04
- XELJANZ (Drug) $293.05
- MAVYRET (Drug) $288.93
- Mavyret (Drug) $274.86
- INFLECTRA (Biological) $246.25
- CREON (Drug) $244.83
- Linzess (Drug) $206.55
- TRULANCE (Drug) $180.46
- SKYRIZI (Biological) $127.53
- VIBERZI (Drug) $124.48
- Epclusa (Drug) $122.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Riverside
Anil Garde, Md, MD
Gastroenterology — Payments: $41,788
Dr. Galen Huang, Md, MD
Gastroenterology — Payments: $15,095
Vinod Mishra, Md, MD
Gastroenterology — Payments: $13,964
Steven Moss, Md, MD
Gastroenterology — Payments: $8,788
Dr. Philip Chen, Md, MD
Gastroenterology — Payments: $8,665
Dr. Amit Srivastava, M.d, M.D
Gastroenterology — Payments: $4,803